"Thioredoxin Reductase 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of thioredoxin reductase found primarily in the CYTOSOL.
Descriptor ID |
D054481
|
MeSH Number(s) |
D08.811.682.667.750.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thioredoxin Reductase 1".
Below are MeSH descriptors whose meaning is more specific than "Thioredoxin Reductase 1".
This graph shows the total number of publications written about "Thioredoxin Reductase 1" by people in this website by year, and whether "Thioredoxin Reductase 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thioredoxin Reductase 1" by people in Profiles.
-
Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells. Oncotarget. 2016 Jan 19; 7(3):3548-58.
-
Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia. Cancer Res. 2014 May 01; 74(9):2520-32.
-
KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer. Cancer Res. 2013 Sep 01; 73(17):5532-43.
-
Genetic dissection of rod and cone pathways in the dark-adapted mouse retina. J Neurophysiol. 2009 Sep; 102(3):1945-55.